A phase II study of sulofenur, a novel sulfonylurea, in recurrent epithelial ovarian cancer
- 1 January 1992
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 30 (3) , 245-248
- https://doi.org/10.1007/bf00686324
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Studies on the cellular pharmacology of N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl)-ureaBiochemical Pharmacology, 1990
- Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compoundsGynecologic Oncology, 1990
- Clinical pharmacology of a novel diarylsulfonylurea anticancer agent.Journal of Clinical Oncology, 1989
- Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trialsBritish Journal of Cancer, 1989
- Evaluation of N-(5-indanylsulfonyl)-N?-(4-chlorophenyl)-urea against xenografts of pediatric rhabdomyosarcomaCancer Chemotherapy and Pharmacology, 1989
- Ovarian trials at the Royal MarsdenCancer Treatment Reviews, 1985